Mete, A. Ö. Et Al. 2024. Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey. ISTANBUL MEDICAL JOURNAL , vol.25, no.1 , 49-55.

Mete, A. Ö., Vahapoğlu, A., Okatar Erözcan, T., Koçak, K., Sarıgül, F., Nazlı, A., ... Dora, D. D.(2024). Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey. ISTANBUL MEDICAL JOURNAL , vol.25, no.1, 49-55.

Mete, Ayşe Et Al. "Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey," ISTANBUL MEDICAL JOURNAL , vol.25, no.1, 49-55, 2024

Mete, Ayşe Ö. Et Al. "Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey." ISTANBUL MEDICAL JOURNAL , vol.25, no.1, pp.49-55, 2024

Mete, A. Ö. Et Al. (2024) . "Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey." ISTANBUL MEDICAL JOURNAL , vol.25, no.1, pp.49-55.

@article{article, author={Ayşe Özlem Mete Et Al. }, title={Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey}, journal={ISTANBUL MEDICAL JOURNAL}, year=2024, pages={49-55} }